HOWL Q1 2023 Earnings — Werewolf Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

HOWLWerewolf Therapeutics, Inc.

$35M

Q1 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$4M

Gross Profit

$4M100.0% margin

Operating Income

-$12M-273.8% margin

Net Income

-$12M-268.4% margin

EPS (Diluted)

$-0.34

QoQ Revenue Growth

-38.7%

Cash Flow

Operating Cash Flow

-$10M

Free Cash Flow

-$10M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$195M

Total Liabilities

$74M

Stockholders' Equity

$121M

Cash & Equivalents

$148M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4M	$0	—
Gross Profit	$4M	$0	—
Operating Income	-$12M	-$15M	+20.5%
Net Income	-$12M	-$15M	+21.9%